SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse Stuttgart
Börse Börse Stuttgart
Symbol NZM2
EUR
  • Novozymes A/S B
    Börse Börse Stuttgart
    Symbol NZM2
    EUR
  • Novozymes A/S B
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol NZM2
    EUR
  • Novozymes A/S B
    Börse Gettex System der Börse München
    Symbol NZM2
    EUR
  • Novozymes A/S B
    Börse Quotrix System der Börse Düsseldorf
    Symbol NZM2
    EUR
  • Novozymes A/S B
    Börse Börse Düsseldorf
    Symbol NZM2
    EUR
  • NOVOZYMES A/S-B SHARES
    Börse Xetra Frankfurt
    Symbol NZM2
    EUR
  • NOVOZYMES B
    Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"
    ISIN DK0060336014
    Symbol NZYMB
    USD
  • Novozymes A/S
    Börse Amerikanscher Freiverkehr OTC oder "Pink Sheets"
  • ISIN DK0060336014 WKN: A1JP9Y
    Symbol NZM2
    EUR
  • Novozymes A/S
    Börse OMXC Copenhagen Stock Exchange
    ISIN DK0060336014
    DKK
  • Symbol NZM2
  • EUR
  • Symbol NZM2
  • Novozymes A/S B
    Börse Freiverkehr OTC
    USD
  • Novozymes A/S
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • Novozymes A/S
    Börse Freiverkehr OTC
Symbol NZM2
Währung EUR
Börse Börse Stuttgart Zeitzone: America/New_York
Marktkapitalisierung 13.734.000.000
Mitarbeiter 6.657

Aktionärsstruktur der Novozymes A/S B

18 News & Informationen zur Novozymes A/S B Aktie

  • Probiotics Market Size to Reach USD 3,257.0 Million by 2025 at a CAGR of 8.48% - Report by Market Research Future (MRFR)
    globenewswire.com

    Probiotics Market Size to Reach USD 3,257.0 Million by 2025 at a CAGR of 8.48% – Report by Market Research Future (MRFR)

    Probiotics Market Insights and Industry Analysis by Type (Bifidobacterium, Lactobacillus and others), Application (Functional Food & Beverages, Dietary…

  • Novo Holdings Leads US$ 118M Series C Investment in Genomatica
    markets.businessinsider.com

    Novo Holdings Leads US$ 118M Series C Investment in Genomatica

    – Financing to amplify the scale and impact of Genomatica's sustainable materials- Underscores Novo Holdings' commitment to support the developmen…

  • Seed Treatment Market Was Worth $6 Billion In 2020: P&S Intelligence
    thestreet.com

    Seed Treatment Market Was Worth $6 Billion In 2020: P&S Intelligence

    NEW YORK, July 26, 2021 /PRNewswire/ — Seed treatment activities are picking up around the world, as the pressure on the agrarian community is mounting due to

  • Seed Treatment Market Was Worth $6 Billion in 2020: P&S Intelligence
    prnewswire.com

    Seed Treatment Market Was Worth $6 Billion in 2020: P&S Intelligence

    /PRNewswire/ — Seed treatment activities are picking up around the world, as the pressure on the agrarian community is mounting due to the booming population….

  • Novo Holdings co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
    prnewswire.com

    Novo Holdings co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

    /PRNewswire/ — Novo Holdings, a leading international life science investor, today announces that it has co-led alongside HealthCap and RA Capital Management…

  • Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
    markets.businessinsider.com

    Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

    COPENHAGEN, Denmark and BOSTON, July 22, 2021 /PRNewswire/ — Hemab ApS ('Hemab'), a biotech company developing next generation therapeutics for s…

  • Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.18% By Investing.com
    investing.com

    Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.18% By Investing.com

    Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.18%

  • Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
    markets.businessinsider.com

    Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

    COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ — Novo Holdings, a global life science investor, today announces that it has co-led the Series A f…

  • Muna Therapeutics Launches With US$ 73M Series A To Advance Novel Small Molecule Therapeutics For Neurodegenerative Diseases
    thestreet.com

    Muna Therapeutics Launches With US$ 73M Series A To Advance Novel Small Molecule Therapeutics For Neurodegenerative Diseases

    COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ — Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for

  • Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
    prnewswire.com

    Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

    /PRNewswire/ — Novo Holdings, a global life science investor, today announces that it has co-led the Series A financing of its portfolio company, Muna…

  • Renaissance Investment Group LLC Buys 3M Co, Novozymes A/S, iShares Russell Mid-Cap Growth ETF, Sells American Tower Corp, The Walt Disney...
    gurufocus.com

    Renaissance Investment Group LLC Buys 3M Co, Novozymes A/S, iShares Russell Mid-Cap Growth ETF, Sells American Tower Corp, The Walt Disney Co, General Electric Co

    GuruFocus Article or News written by insider and the topic is about:

  • Novozymes A/S : Bringing the power to stop climate change to consumers' hands
    marketscreener.com

    Novozymes A/S : Bringing the power to stop climate change to consumers' hands

    a trade association for the U.S. cleaning products industry – has issued a challenge for its members to take action to mitigate climate change and align with worldwide efforts to limit global average… | June 24, 2021

  • Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.97% By Investing.com
    investing.com

    Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.97% By Investing.com

    Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.97%

  • Novozymes A/S : ' biosolutions to be considered as part of Amager Resource Center's (ARC) carbon capture project
    marketscreener.com

    Novozymes A/S : ' biosolutions to be considered as part of Amager Resource Center's (ARC) carbon capture project

    23 June 2021 – Novozymes, the world leader in biological solutions, is included as part of ARC´s EU application to set up a carbon capture facility at the Amager Resource Center … | June 24, 2021

  • Industrial Enzymes Market to Grow Significantly at 6.3% CAGR from 2020 to 2027 - Report by Market Research Future (MRFR)
    globenewswire.com

    Industrial Enzymes Market to Grow Significantly at 6.3% CAGR from 2020 to 2027 – Report by Market Research Future (MRFR)

    Industrial Enzymes Market Insights and Industry Analysis by Type (Carbohydrases [Amylase, Glucanase, Cellulase and others], Proteases, Lipases and others),…

  • Outlook on the Inoculants Global Market to 2027 - by Crop Type, Type, Microbes and Geography
    benzinga.com

    Outlook on the Inoculants Global Market to 2027 – by Crop Type, Type, Microbes and Geography

    Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) — The

  • Drastic Effects of Climate Change Expected to Enhance the Growth of the Global Specialty Water Treatment Market by the end of 2026 - [400...
    benzinga.com

    Drastic Effects of Climate Change Expected to Enhance the Growth of the Global Specialty Water Treatment Market by the end of 2026 – [400 pages] Exclusive Report by Research Dive

    New York, USA, Jan. 05, 2021 (GLOBE NEWSWIRE) — According to a report published by Research Dive, the global specialty water treatment market is …

  • Novozymes: An Opportunity For Conservative Investors
    aktienfinder.net

    Novozymes: An Opportunity For Conservative Investors

    Mein neuester Beitrag auf Seeking Alpha geht um Novozymes, eine dänische Firma, die Weltmarktführer im Bereich der Erforschung und Vermarktung von Enzymen ist. …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen Novozymes A/S B am höchsten gewichtet ist Insgesamt in 39 ETFs enthalten

Dir gefallen die Informationen zu Novozymes A/S B?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Novozymes A/S B?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Novozymes A/S B?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Novozymes A/S B?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero